Rocket pharmaceuticals, inc. (RCKT)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
Operating Activities:
Net loss

-82,483

-77,270

-84,734

-81,539

-78,626

-74,518

-53,854

-44,489

-32,243

-19,578

-25,897

-30,301

-35,464

-42,854

-38,052

-82,885

-76,588

-67,982

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Accretion of discount on convertible notes

3,596

3,602

3,468

3,338

3,213

3,059

2,241

1,454

696

0

0

0

0

-

-

-

-

-

-

-

-

Amount of amortization of operating lease right-of-use assets under operating lease.

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Amount of reduction in lease liability.

190

0

0

0

0

-

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-

Depreciation expense

442

426

422

377

349

330

295

280

259

204

200

178

160

169

149

116

82

45

0

0

0

Write down of property and equipment

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-267

0

0

0

Change in fair value of Convertible Bridge Notes redemption rights derivative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-480

0

0

0

Change in fair value of 2020 Convertible Notes derivative liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-42,793

0

0

0

Stock-based compensation

14,152

13,371

12,833

12,752

11,399

13,601

11,138

9,227

6,603

1,320

1,893

1,997

2,522

2,909

2,426

1,995

1,502

2,380

0

0

0

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,239

0

0

0

Amortization of premium on short term investments

-

-

-

-

-

-

-

-

0

-

-

-

182

225

0

0

0

-

-

-

-

Noncash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,132

0

0

0

Amount of rent expense or loss included in net income that result in non cash flow.

-

-

-

-

-

-

-

-

-

-

-

-

-

60

0

0

0

-

-

-

-

The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of discount on investments

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Prepaid expenses and other assets

881

917

3,599

3,252

1,546

1,505

0

0

0

-

-

-

-

948

628

182

933

1,256

0

0

0

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

-4,570

-2,722

7,056

2,960

7,951

5,890

3,053

3,509

949

2,812

0

0

0

-

-

-

-

-

-

-

-

Amount of increase (decrease) in present value of lessee's discounted obligation for lease payments from operating lease.

-329

-87

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Amount of increase (decrease) in present value of lessee's discounted obligation for lease payments from finance lease.

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-41

68

108

76

487

0

0

0

Accrued expenses and other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

3,112

2,610

1,429

1,998

1,438

0

0

0

Accrued research and development costs

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Net cash used in operating activities

-70,931

-64,663

-65,744

-66,530

-58,164

-53,788

-38,963

-31,422

-23,840

-15,962

-21,111

-26,149

-31,996

-37,266

-33,167

-28,362

-24,416

-17,416

0

0

0

Investing activities:
Cash acquired in connection with the Reverse Merger

-

-

-

-

-

76,348

76,348

76,348

76,348

0

0

0

0

-

-

-

-

-

-

-

-

Purchases of investments

207,779

184,298

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

122,277

0

0

0

-

-

-

-

Proceeds from maturities of investments

195,426

168,556

121,757

89,980

81,493

61,276

41,255

21,232

9,718

0

11,069

27,764

44,872

56,705

0

0

0

-

-

-

-

The cash outflow for payments made to acquire right of use asset.

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of property and equipment

-

-

-

-

-

20

20

20

20

0

0

0

0

-

-

-

-

-

-

-

-

Purchases of property and equipment

27,716

23,269

14,898

8,641

2,205

1,453

600

148

637

760

0

0

0

-

-

-

-

-

-

-

-

Purchases of internal use software

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by investing activities

-40,687

-39,011

-43,476

-81,641

-62,175

-5,272

-24,351

-21,367

85,449

-760

-43,011

-38,079

-53,847

-66,059

0

0

0

-

-

-

-

Financing activities:
Proceeds from sale of treasury stock

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of convertible preferred stock, net

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Common stock repurchase

72

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net proceeds from issuance of common stock in initial public offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

38,085

0

0

0

Proceeds from issuance of 2020 Convertible Notes in initial public offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

21,000

0

0

0

Gross proceeds, offering amount

-

-

-

-

-

154,022

78,518

78,518

78,518

0

0

0

0

-

-

-

-

-

-

-

-

Purchase of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

487

0

0

0

-

-

-

-

Convertible notes refinancing costs to the lender

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Principal payments on notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,800

0

0

0

Net cash used in financing activities

177,674

177,791

160,219

160,337

74,984

153,502

78,667

78,479

82,375

25,406

0

0

0

-

-

-

-

125,515

0

0

0

Net change in cash, cash equivalents and restricted cash

66,056

74,117

50,999

12,166

-45,355

94,442

15,353

25,690

143,984

8,684

-38,503

10,116

-11,213

-50,244

-6,244

-10,493

5,567

76,424

0

0

0

Supplemental disclosure of non-cash financing and investing activities:
Accrued purchases of property and equipment

2,828

4,424

3,535

716

4,392

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Accrued purchases of internal use software

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

The fair value of retired treasury stock in noncash investing and financing activities.

70

1,393

1,393

1,395

1,395

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Amount of withholding tax payable on shares withheld in treasury stock classified as noncash financing activities.

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of convertible preferred stock into common stock

-

-

-

-

-

41,466

41,466

41,466

41,466

0

0

0

0

-

-

-

-

-

-

-

-

Unrealized (loss) gain on investments

14

147

324

223

-89

-127

0

0

0

-

-

-

-

-43

0

0

0

-

-

-

-

Finance lease right of use asset and lease liability

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reclassification of construction in process of finance lease right of use asset.

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental cash flow information:
Cash paid for interest

2,990

2,990

4,485

4,485

4,485

4,485

2,990

1,495

1,495

0

0

0

0

-

-

-

-

89

0

0

0

Cash paid for income taxes

-

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-